Abstract:Background: Ovarian cancer has the highest mortality rate among gynecologic cancers, and most patients are diagnosed in advanced stages. Enhancer of zeste homolog 2 (EZH2) is a major tumor marker and an effective therapeutic target for ovarian cancer, but the underlying molecular mechanism remains unclear. The present study investigated the biological effects of EZH2 knockout in SKOV3 cells in vitro and in vivo and explored the molecular mechanism by integrated analysis of messenger RNA sequencing (mRNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) data.Methods: The CRISPR/Cas9 system was used to establish EZH2 knockout SKOV3 cells. Protein expression was evaluated by Western blotting. The effect of EZH2 on ovarian cancer was evaluated in vitro with MTT, wound healing, Transwell, and apoptosis assays and in vivo with a xenograft model. mRNA-seq and ChIP-seq were performed to explore the molecular mechanism underlying the biological function of EZH2. Immunohistochemical staining (IHC) of tissue arrays was used to analyze the correlations among EZH2 and CYP27B1 expressions and prognosis.Results: We obtained three EZH2 knockout subclones. EZH2 knockout SKOV3 cells exhibited significantly suppressed proliferation, migration, and invasion and a significantly increased apoptosis rate. The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. Integrated analysis of the mRNA-seq and ChIP-seq data identified 1,455 significantly upregulated genes with matching downregulated trimethylation of histone H3 lysine 27 (H3K27me3) methylation binding sites in 1b11H cells compared to SKOV3 cells. The set of downregulated genes in EZH2 knockout cells was highly enriched in genes regulating the activation of steroid biosynthesis; the top-ranked hub gene was CYP27B1. The EZH2 and CYP27B1 expression levels showed a statistically significant inverse correlation, which was also associated with unfavorable prognosis. The in vitro experiment demonstrated that CYP27B1 can suppress the proliferation, migration, and invasion of ovarian cancer cells. Moreover, the levels of AKT and p-AKT were significantly increased, whereas STAT3 was downregulated, in 1b11H cells compared to SKOV3 cells. Moreover, STAT3 and AKT overexpression was observed in 1b11H siRNA for CYP27B1 (siCYP27B1) cells.Conclusion: EZH2 plays an important role in promoting cell proliferation, migration, and invasion in ovarian cancer by regulating the core steroid biosynthesis gene via H3K27me3 methylation. Moreover, CYP27B1, the steroid biosynthesis hub gene, might be a novel therapeutic target for ovarian cancer.

CYP27A1 Inhibits Bladder Cancer Cells Proliferation by Regulating Cholesterol Homeostasis.

CYP27A1 inhibits proliferation and migration of clear cell renal cell carcinoma via activation of LXRs/ABCA1

Oncogenic Role of MIR516A in Human Bladder Cancer Was Mediated by Its Attenuating PHLPP2 Expression and BECN1-dependent Autophagy.

C/EBPβ Promotes the Viability of Human Bladder Cancer Cell by Contributing to the Transcription of Bladder Cancer Specific Lncrna UCA1.

Research progress on the role of CYP27A1 in tumor progression

Long Non-Coding RNA UCA1 Regulated Cell Cycle Distribution Via CREB Through PI3-K Dependent Pathway in Bladder Carcinoma Cells.

Down-regulation of astrocyte elevated gene-1 expression inhibits the proliferation and invasion of human bladder cancer T24 cells

m6A-Mediated Induction of 7-Dehydrocholesterol Reductase Stimulates Cholesterol Synthesis and cAMP Signaling to Promote Bladder Cancer Metastasis

Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.

Hypoxia Regulates the Expression and Localization of CCAAT/enhancer Binding Protein Α by Hypoxia Inducible Factor-1Α in Bladder Transitional Carcinoma Cells

The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo

CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer

Cancer-associated Fibroblasts Promote Cell Proliferation and Invasion Via Paracrine Wnt/IL1β Signaling Pathway in Human Bladder Cancer.

Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition

Long Non-Coding RNA Urothelial Carcinoma Associated 1 Induces Cell Replication by Inhibiting BRG1 in 5637 Cells

Targeting of MCT1 and PFKFB3 Influences Cell Proliferation and Apoptosis in Bladder Cancer by Altering the Tumor Microenvironment.

NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer

CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity

MP85-07 URINARY MIRNAS AS A PREDICTOR OF TUMOR RECURRENCE IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA

CIP2A Mediates Fibronectin-Induced Bladder Cancer Cell Proliferation by Stabilizing Β-Catenin

Depletion of CDC5L inhibits bladder cancer tumorigenesis.